Starpharma Holdings (Starpharma Holdings) Price-to-Tangible-Book : 1.34 (As of May. 02, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Starpharma Holdings Price-to-Tangible-Book?

As of today (2024-05-02), Starpharma Holdings's share price is $0.75. Starpharma Holdings's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.56. Hence, Starpharma Holdings's Price to Tangible Book Ratio of today is 1.34.

The historical rank and industry rank for Starpharma Holdings's Price-to-Tangible-Book or its related term are showing as below:

SPHRY' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.36 Med: 8.02 Max: 13.39
Current: 1.36

During the past 13 years, Starpharma Holdings's highest Price to Tangible Book Ratio was 13.39. The lowest was 1.36. And the median was 8.02.

SPHRY's Price-to-Tangible-Book is ranked better than
73.4% of 1222 companies
in the Biotechnology industry
Industry Median: 2.71 vs SPHRY: 1.36

A closely related ratio is called PB Ratio. As of today, Starpharma Holdings's share price is $0.75. Starpharma Holdings's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.56. Hence, Starpharma Holdings's P/B Ratio of today is 1.34.

Starpharma Holdings Price-to-Tangible-Book Historical Data

The historical data trend for Starpharma Holdings's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Price-to-Tangible-Book Chart

Starpharma Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

Get a 7-Day Free Trial

12.34

14.02

9.55

5.70

3.69

Starpharma Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															9.80	5.70	5.38	3.69	2.22

Competitive Comparison of Starpharma Holdings's Price-to-Tangible-Book

For the Biotechnology subindustry, Starpharma Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Starpharma Holdings's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Starpharma Holdings's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Starpharma Holdings's Price-to-Tangible-Book falls into.

Starpharma Holdings Price-to-Tangible-Book Calculation

Starpharma Holdings's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.75	/	0.56
	=	1.34

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Starpharma Holdings Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Starpharma Holdings's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Starpharma Holdings (Starpharma Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (OTCPK:SPHRY) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

SPHRF:USA PQ6:Germany SPL:Australia

Address

4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.starpharma.com

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.